What's hot
View all perspectives
What's Hot
Rheumatoid Arthritis Comorbidities
Dr. Jonathan Kay reviews rheumatoid arthritis studies presented on day at EULAR 2022. Specifically, he discusses abstracts OP0132, OP0135 and OP0138.
Watch video →
Increasing Secukinumab Dose in Ankylosing Spondylitis Nonresponders
Dr. Peter Nash discusses abstract OP0023 from EULAR 2022.
Watch video →
DMARDS, Prednisone, Pregnancy, OH MY!
Dr. Kathryn Dao discusses abstracts POS1405, POS0696 and OP0130 presented at the EULAR 2022 meeting. Watch more videos from EULAR 2022 here: https://rheumnow.com/videos.
Watch video →
Breathing New Insight into RA Interstitial Lung Disease
Dr. Jonathan Kay reviews EULAR 2022 abstracts OP0132, OP0306, and OP0307.
Watch video →
EULAR 2022 - Day 4 Faculty Panel Recap
Dr. David Liew and Dr. Jack Cush discuss day 4 of EULAR 2022. LB0001, LB0002, LB0004, and LB0006.
Watch video →
Getting to the Heart of JAK Inhibitors
Dr. Jonathan Kay reviews rheumatoid arthritis sessions and abstracts from day 3 at EULAR 2022. Abstracts reviewed: OP0266; OP0258; and OP0269.
Watch video →
EULAR 2022 - Day 3 Faculty Panel Recap
Drs. Jack Cush, Janet Pope, Aurelie Najm and Yuz Yusof discuss highlights from Day 3 of EULAR 2022.
Watch video →
Deucravacitinib at EULAR 2022
Dr. Peter Nash provides and update on the TYK2 inhibitor, Deucravacitinib with reports on: - Safety of Deucravacitinib https://bit.ly/3NtZQxe - Deucravacitinib in SLE https://bit.ly/3Mh5nG0
Watch video →
Another Take on the 2022 EULAR RA Treatment Guidelines
Dr. Peter Nash reviews the new 2022 EULAR RA Treatment Guidelines, presented at #EULAR2022.
Watch video →
EULAR 2022 - Day 2 Faculty Recap Panel
Dr. Jack Cush, Dr. Robert Chao and Dr. Richard Conway discuss interesting abstracts and seminars from day 2 at EULAR 2022.
Watch video →
2022 ASAS/EULAR Recommendations on the Management of Axial Spondyloarthritis
Dr. Peter Nash discusses the new ASAS/EULAR Spondyloarthritis treatment guidelines presented at EULAR 2022
Watch video →
RA Potpourri on Day One EULAR 2022: Not An Ugly Duckling
Dr. Jonathan Kay reports on RA-related sessions and abstracts from day 1 at EULAR 2022.
Watch video →
New 2022 ASAS/EULAR Recommendations on the Management of AxSpA
Dr. Sophia Ramiro (Leiden University Medical Center) presents an overview of the new Spondyloarthritis treatment guidelines from ASAS/EULAR Task Force.
Watch video →
EULAR 2022 - Day 1 Faculty Recap Panel
Drs. Jack Cush, Eric Dein and Kathryn Dao discuss highlights from day 1 at EULAR 2022 - Guidelines, Lupus, and more.
Watch video →
By now, those of us attending the meeting know how to find a free coffee or sprite, have found comfortable meeting nooks and know our way around! PAnd congrats to you virtual Rheums for mastering the multi-screen, multitask simultaneous consumption posters, tweets and oral abstract presentations.
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 7 months ago
#OP0279 #EULAR2022 Let's start with N=5! Promising new therapy CAR T-cell in #lupus. All patients were refractory to various therapies and had active nephritis. Post-treatment, all responded clinically and serologically! Need to go to RCT next @RheumNow https://t.co/RaTlVALQqn
Eric Dein ericdeinmd
3 years 7 months ago
Difficult to Treat RA (D2TRA): Jacob van Laar
#EULAR2022 Points to consider @RheumNow
1. Consider the diagnosis! Misdiagnosis or mimic?
2. U/s when in doubt
3. Caution in comorbidities (obesity, fm) which can overestimate inflamm markers, disease activity https://t.co/YT9NRv7EA0
Aurelie Najm AurelieRheumo
3 years 7 months ago
@eular_org Systematic Literature Review #workstatus in #RMDs
vs. general pop.
% manuscrits describing worse outcomes:
-unemployment 67%
-work disability/stop work
91%
-absenteeism 92%
Time to collaborate w/ policy makers to reduce employment gap!
#EULAR2022 @RheumNow
POS0160
David Liew drdavidliew
3 years 7 months ago
After linking ultra-processed food with developing autoimmune disease in at-risk individuals, we clarified:
What is an ultra-processed food?
has undergone mechanic or enzymatic processing
Not all bread is the same.
Dietary surveys fail on this.
Joao Sabino #EULAR2022 @RheumNow https://t.co/RIRagCe4nd
David Liew drdavidliew
3 years 7 months ago
Does diet drive IL-23 in IBD and PsA? Perhaps if you have the right baseline risk. The science is evolving quickly
Stronger rationale that diet may be really important in some patients
#EULAR2022 #IL23 @RheumNow https://t.co/hV54PvfOXV
David Liew drdavidliew
3 years 7 months ago
Incidentally looked at the FLORA study in @RheumNow Tuesday Night Rheumatology for ‘PsA All The Way’, a month before #EULAR2022
https://t.co/s5qa4breCf
https://t.co/a52myvJMMc
Dr. John Cush RheumNow
3 years 7 months ago
Watch: AURORA-2 Two-year Results Voclosporin For Lupus Nephritis
https://t.co/k61KOBXRSl
#EULAR2022 https://t.co/Q7cjqvQyFG
TheDaoIndex KDAO2011
3 years 7 months ago
“Modify medications, work on lifestyle (weight loss/exercise), and emphasize patience.”
- Prof van Lear on managing difficult to treat RA
#EULAR2022 @rheumnow
Dr Ai Lyn Tan DrAiLynTan
3 years 7 months ago
#COVID19 #pandemic has affected #rheumatology training
Negative impact on
▶️Learning
▶️Research
▶️Mental health
▶️Physical health
👉🏽https://t.co/Irtkg8TjZt
By @kristenyoung @SuAnnYeoh1 @EBRheum @SattuiSEMD @RichardPAConway @SituationRheum @KilianMD @rheum_covid et al @RheumJnl https://t.co/wysWzE92Fm
Poster Hall